Key result
Higher pulmonary vascular resistance was a major determinant of all-cause mortality, increasing the risk of death by 10% per 1 Wood unit increase in patients with persistent pulmonary hypertension after corrected valvular heart disease.
Why the study?
The determinants and consequences of pulmonary hypertension after successfully corrected valvular heart disease remain poorly understood.
Cohort (n=222)
Yes
Hazard Ratio: 1.1 (95% CI 1.01–1.19)
p-value: p=0.04
High PVR signals elevated mortality risk in persistent post-correction PH; extends hemodynamic risk stratification in valvular disease.
Background The determinants and consequences of pulmonary hypertension after successfully corrected valvular heart disease remain poorly understood. We aim to clarify the hemodynamic bases and risk factors for mortality in patients with this condition. Methods and Results We analyzed long-term follow-up data of 222 patients with pulmonary hypertension and valvular heart disease successfully corrected at least 1 year before enrollment who had undergone comprehensive hemodynamic and imaging characterization as per the SIOVAC (Sildenafil for Improving Outcomes After Valvular Correction) clinical trial. Median (interquartile range) mean pulmonary pressure was 37 mm Hg (32-44 mm Hg) and pulmonary artery wedge pressure was 23 mm Hg (18-26 mm Hg). Most patients were classified either as having combined precapillary and postcapillary or isolated postcapillary pulmonary hypertension. After a median follow-up of 4.5 years, 91 deaths accounted for 4.21 higher-than-expected mortality in the age-matched population. Risk factors for mortality were male sex, older age, diabetes mellitus, World Health Organization functional class III and higher pulmonary vascular resistance-either measured by catheterization or approximated from ultrasound data. Higher pulmonary vascular resistance was related to diabetes mellitus and smaller residual aortic and mitral valve areas. In turn, the latter correlated with prosthetic nominal size. Six-month changes in the composite clinical score and in the 6-minute walk test distance were related to survival. Conclusions Persistent valvular heart disease-pulmonary hypertension is an ominous disease that is almost universally associated with elevated pulmonary artery wedge pressure. Pulmonary vascular resistance is a major determinant of mortality in this condition and is related to diabetes mellitus and the residual effective area of the corrected valve. These findings have important implications for individualizing valve correction procedures. Registration URL: https://www.clinicaltrials.gov; Unique identifier: NCT00862043.
No takes yet. Share an insight, caveat, or question.
Bermejo et al. (2021) conducted a cohort in Persistent pulmonary hypertension in corrected valvular heart disease (n=222). Higher pulmonary vascular resistance vs. Lower pulmonary vascular resistance was evaluated on All-cause mortality (HR 1.10, 95% CI 1.01-1.19, p=0.04). Higher pulmonary vascular resistance was a major determinant of all-cause mortality, increasing the risk of death by 10% per 1 Wood unit increase in patients with persistent pulmonary hypertension after corrected valvular heart disease.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: